Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Amgen and Boehringer drugs win FDA breakthrough status

Leukaemia drug and Pradaxa antidote will benefit from accelerated regulatory processes

- PMLiVE

Antares CEO Wotton resigns

He will move to Advanced Cell Technology

Ashfield team picks up Lilly sales award

Syndicated pharma sales team rewarded with supplier prize

- PMLiVE

Merck could win anti-PD1 therapy race in Europe

EMA accepts filing for promising pembrolizumab in melanoma

- PMLiVE

Erbitux betters Avastin in bowel cancer subgroup

Data backs Merck KGaA drug over Roche’s rival in RAS wild-type metastatic colorectal cancer

Allergan logo

Allergan will start phase III DARPin trials next year

Will investigate drug in wet age-related macular degeneration

- PMLiVE

UK innovation prize to support antibiotic diagnostics

Longitude Prize 2014 offers £10m to develop tool to fight antimicrobial resistance

- PMLiVE

JPA strengthens PR offering

Three new employees join the agency’s London office

- PMLiVE

Merck & Co extends med ed portal to India

Pharma company makes Univadis accessible to yet more healthcare professionals

Healthcare marketing compliance in the UK – prevention beats cure

UK's MHRA gives its views on rep training, pharma advertising and social media

- PMLiVE

Introducing pharma perspectives

Matt de Gruchy outlines the HCC's forthcoming collaboration with PME

- PMLiVE

Lundbeck’s desmoteplase flunks phase III stroke trial

No better than placebo at improving disability symptoms

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links